For instance, changes (e.g., mutation and methylation) in the serum DNAs (ctDNAs), such as MGMT 7-9, EGFR 10, and PTEN 9, have been proven to be effective biomarkers of glioma and may have the potential for the diagnosis of glioma. Here, PTEN is linked to central nervous system cancer.